Epoetin alfa biosimilar (Intas BioPharmaceuticals)
阿法依伯汀生物类似药 (Intas BioPharmaceuticals)
Report date: 2022/12/30 16:25:45
Base Information
Drug NameEpoetin alfa biosimilar (Intas BioPharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIntas Biopharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesIntas BiopharmaceuticalsScigen Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A